nodes	percent_of_prediction	percent_of_DWPC	metapath
Donepezil—ACHE—kidney cancer	0.496	1	CbGaD
Donepezil—CYP2D6—Temsirolimus—kidney cancer	0.0392	0.139	CbGbCtD
Donepezil—CYP3A4—Everolimus—kidney cancer	0.0369	0.13	CbGbCtD
Donepezil—CYP3A4—Temsirolimus—kidney cancer	0.0249	0.0881	CbGbCtD
Donepezil—CYP2C9—Capecitabine—kidney cancer	0.0235	0.0831	CbGbCtD
Donepezil—CYP2D6—Pazopanib—kidney cancer	0.0206	0.0728	CbGbCtD
Donepezil—CYP2C9—Paclitaxel—kidney cancer	0.0147	0.052	CbGbCtD
Donepezil—CYP2D6—Erlotinib—kidney cancer	0.0147	0.052	CbGbCtD
Donepezil—CYP3A4—Pazopanib—kidney cancer	0.0131	0.0463	CbGbCtD
Donepezil—CYP2C9—Sorafenib—kidney cancer	0.013	0.0462	CbGbCtD
Donepezil—CYP2D6—Sorafenib—kidney cancer	0.0119	0.0423	CbGbCtD
Donepezil—CYP2D6—Vinblastine—kidney cancer	0.0118	0.0417	CbGbCtD
Donepezil—CYP3A4—Erlotinib—kidney cancer	0.00933	0.033	CbGbCtD
Donepezil—CYP3A4—Paclitaxel—kidney cancer	0.00854	0.0302	CbGbCtD
Donepezil—CYP3A4—Sorafenib—kidney cancer	0.00759	0.0269	CbGbCtD
Donepezil—CYP3A4—Vinblastine—kidney cancer	0.00749	0.0265	CbGbCtD
Donepezil—CYP3A4—Vincristine—kidney cancer	0.00737	0.0261	CbGbCtD
Donepezil—CYP2D6—Doxorubicin—kidney cancer	0.00724	0.0256	CbGbCtD
Donepezil—CYP3A4—Sunitinib—kidney cancer	0.00615	0.0218	CbGbCtD
Donepezil—CYP3A4—Doxorubicin—kidney cancer	0.0046	0.0163	CbGbCtD
Donepezil—CYP2C9—urine—kidney cancer	0.000297	0.174	CbGeAlD
Donepezil—HTR2A—urine—kidney cancer	0.000244	0.143	CbGeAlD
Donepezil—CYP3A4—urine—kidney cancer	0.000226	0.133	CbGeAlD
Donepezil—CYP2D6—urine—kidney cancer	0.000223	0.13	CbGeAlD
Donepezil—SIGMAR1—nephron tubule—kidney cancer	0.000123	0.0723	CbGeAlD
Donepezil—SIGMAR1—cortex of kidney—kidney cancer	0.000106	0.0619	CbGeAlD
Donepezil—SIGMAR1—cardiac atrium—kidney cancer	0.000101	0.0589	CbGeAlD
Donepezil—Gastrointestinal pain—Vincristine—kidney cancer	6.05e-05	0.000295	CcSEcCtD
Donepezil—Dizziness—Sorafenib—kidney cancer	6.01e-05	0.000293	CcSEcCtD
Donepezil—Pain—Gemcitabine—kidney cancer	6e-05	0.000293	CcSEcCtD
Donepezil—Constipation—Gemcitabine—kidney cancer	6e-05	0.000293	CcSEcCtD
Donepezil—Nausea—Erlotinib—kidney cancer	6e-05	0.000293	CcSEcCtD
Donepezil—Alopecia—Capecitabine—kidney cancer	6e-05	0.000293	CcSEcCtD
Donepezil—Dry mouth—Paclitaxel—kidney cancer	6e-05	0.000293	CcSEcCtD
Donepezil—Mood swings—Doxorubicin—kidney cancer	5.99e-05	0.000293	CcSEcCtD
Donepezil—Diarrhoea—Sunitinib—kidney cancer	5.99e-05	0.000292	CcSEcCtD
Donepezil—HTR2A—renal system—kidney cancer	5.98e-05	0.035	CbGeAlD
Donepezil—Ataxia—Doxorubicin—kidney cancer	5.95e-05	0.00029	CcSEcCtD
Donepezil—Mental disorder—Capecitabine—kidney cancer	5.95e-05	0.00029	CcSEcCtD
Donepezil—Asthenia—Dactinomycin—kidney cancer	5.94e-05	0.00029	CcSEcCtD
Donepezil—Confusional state—Paclitaxel—kidney cancer	5.93e-05	0.000289	CcSEcCtD
Donepezil—Blood creatinine increased—Doxorubicin—kidney cancer	5.93e-05	0.000289	CcSEcCtD
Donepezil—Malnutrition—Capecitabine—kidney cancer	5.91e-05	0.000288	CcSEcCtD
Donepezil—Erythema—Capecitabine—kidney cancer	5.91e-05	0.000288	CcSEcCtD
Donepezil—Dehydration—Doxorubicin—kidney cancer	5.88e-05	0.000287	CcSEcCtD
Donepezil—Oedema—Paclitaxel—kidney cancer	5.88e-05	0.000287	CcSEcCtD
Donepezil—Body temperature increased—Vincristine—kidney cancer	5.85e-05	0.000286	CcSEcCtD
Donepezil—Abdominal pain—Vincristine—kidney cancer	5.85e-05	0.000286	CcSEcCtD
Donepezil—Liver function test abnormal—Doxorubicin—kidney cancer	5.84e-05	0.000285	CcSEcCtD
Donepezil—Infection—Paclitaxel—kidney cancer	5.84e-05	0.000285	CcSEcCtD
Donepezil—Flatulence—Capecitabine—kidney cancer	5.82e-05	0.000284	CcSEcCtD
Donepezil—Dry skin—Doxorubicin—kidney cancer	5.8e-05	0.000283	CcSEcCtD
Donepezil—Dysgeusia—Capecitabine—kidney cancer	5.79e-05	0.000283	CcSEcCtD
Donepezil—Dizziness—Sunitinib—kidney cancer	5.79e-05	0.000282	CcSEcCtD
Donepezil—Feeling abnormal—Gemcitabine—kidney cancer	5.78e-05	0.000282	CcSEcCtD
Donepezil—Shock—Paclitaxel—kidney cancer	5.78e-05	0.000282	CcSEcCtD
Donepezil—Vomiting—Sorafenib—kidney cancer	5.78e-05	0.000282	CcSEcCtD
Donepezil—HTR2A—kidney—kidney cancer	5.78e-05	0.0339	CbGeAlD
Donepezil—Orthostatic hypotension—Doxorubicin—kidney cancer	5.78e-05	0.000282	CcSEcCtD
Donepezil—Abdominal pain upper—Doxorubicin—kidney cancer	5.78e-05	0.000282	CcSEcCtD
Donepezil—Nervous system disorder—Paclitaxel—kidney cancer	5.76e-05	0.000281	CcSEcCtD
Donepezil—Hypokalaemia—Doxorubicin—kidney cancer	5.76e-05	0.000281	CcSEcCtD
Donepezil—Thrombocytopenia—Paclitaxel—kidney cancer	5.75e-05	0.000281	CcSEcCtD
Donepezil—Rash—Sorafenib—kidney cancer	5.73e-05	0.00028	CcSEcCtD
Donepezil—Dermatitis—Sorafenib—kidney cancer	5.73e-05	0.00028	CcSEcCtD
Donepezil—Back pain—Capecitabine—kidney cancer	5.72e-05	0.000279	CcSEcCtD
Donepezil—Aspartate aminotransferase increased—Doxorubicin—kidney cancer	5.7e-05	0.000278	CcSEcCtD
Donepezil—Headache—Sorafenib—kidney cancer	5.7e-05	0.000278	CcSEcCtD
Donepezil—Muscle spasms—Capecitabine—kidney cancer	5.68e-05	0.000277	CcSEcCtD
Donepezil—Hyperhidrosis—Paclitaxel—kidney cancer	5.68e-05	0.000277	CcSEcCtD
Donepezil—Diarrhoea—Dactinomycin—kidney cancer	5.67e-05	0.000277	CcSEcCtD
Donepezil—Nasopharyngitis—Doxorubicin—kidney cancer	5.66e-05	0.000276	CcSEcCtD
Donepezil—Anorexia—Paclitaxel—kidney cancer	5.6e-05	0.000273	CcSEcCtD
Donepezil—Gastritis—Doxorubicin—kidney cancer	5.6e-05	0.000273	CcSEcCtD
Donepezil—Alanine aminotransferase increased—Doxorubicin—kidney cancer	5.58e-05	0.000272	CcSEcCtD
Donepezil—Muscular weakness—Doxorubicin—kidney cancer	5.58e-05	0.000272	CcSEcCtD
Donepezil—Vision blurred—Capecitabine—kidney cancer	5.57e-05	0.000272	CcSEcCtD
Donepezil—Vomiting—Sunitinib—kidney cancer	5.56e-05	0.000272	CcSEcCtD
Donepezil—Body temperature increased—Gemcitabine—kidney cancer	5.55e-05	0.000271	CcSEcCtD
Donepezil—Tremor—Capecitabine—kidney cancer	5.54e-05	0.00027	CcSEcCtD
Donepezil—CYP3A4—renal system—kidney cancer	5.54e-05	0.0324	CbGeAlD
Donepezil—Rash—Sunitinib—kidney cancer	5.52e-05	0.000269	CcSEcCtD
Donepezil—Dermatitis—Sunitinib—kidney cancer	5.51e-05	0.000269	CcSEcCtD
Donepezil—Abdominal distension—Doxorubicin—kidney cancer	5.5e-05	0.000269	CcSEcCtD
Donepezil—Hypotension—Paclitaxel—kidney cancer	5.49e-05	0.000268	CcSEcCtD
Donepezil—Ill-defined disorder—Capecitabine—kidney cancer	5.48e-05	0.000268	CcSEcCtD
Donepezil—Headache—Sunitinib—kidney cancer	5.48e-05	0.000268	CcSEcCtD
Donepezil—Influenza—Doxorubicin—kidney cancer	5.47e-05	0.000267	CcSEcCtD
Donepezil—Dysphagia—Doxorubicin—kidney cancer	5.47e-05	0.000267	CcSEcCtD
Donepezil—Asthma—Doxorubicin—kidney cancer	5.47e-05	0.000267	CcSEcCtD
Donepezil—Anaemia—Capecitabine—kidney cancer	5.46e-05	0.000267	CcSEcCtD
Donepezil—Hypersensitivity—Vincristine—kidney cancer	5.45e-05	0.000266	CcSEcCtD
Donepezil—CYP2D6—renal system—kidney cancer	5.45e-05	0.0319	CbGeAlD
Donepezil—Eosinophilia—Doxorubicin—kidney cancer	5.41e-05	0.000264	CcSEcCtD
Donepezil—Nausea—Sorafenib—kidney cancer	5.4e-05	0.000264	CcSEcCtD
Donepezil—HTR2A—gonad—kidney cancer	5.36e-05	0.0314	CbGeAlD
Donepezil—Pancreatitis—Doxorubicin—kidney cancer	5.36e-05	0.000262	CcSEcCtD
Donepezil—Musculoskeletal discomfort—Paclitaxel—kidney cancer	5.35e-05	0.000261	CcSEcCtD
Donepezil—CYP3A4—kidney—kidney cancer	5.35e-05	0.0314	CbGeAlD
Donepezil—Malaise—Capecitabine—kidney cancer	5.33e-05	0.00026	CcSEcCtD
Donepezil—Angina pectoris—Doxorubicin—kidney cancer	5.33e-05	0.00026	CcSEcCtD
Donepezil—Insomnia—Paclitaxel—kidney cancer	5.32e-05	0.000259	CcSEcCtD
Donepezil—Vertigo—Capecitabine—kidney cancer	5.31e-05	0.000259	CcSEcCtD
Donepezil—Asthenia—Vincristine—kidney cancer	5.31e-05	0.000259	CcSEcCtD
Donepezil—Syncope—Capecitabine—kidney cancer	5.3e-05	0.000259	CcSEcCtD
Donepezil—Paraesthesia—Paclitaxel—kidney cancer	5.28e-05	0.000258	CcSEcCtD
Donepezil—CYP2D6—kidney—kidney cancer	5.27e-05	0.0309	CbGeAlD
Donepezil—Vomiting—Dactinomycin—kidney cancer	5.27e-05	0.000257	CcSEcCtD
Donepezil—Bronchitis—Doxorubicin—kidney cancer	5.26e-05	0.000257	CcSEcCtD
Donepezil—Dyspnoea—Paclitaxel—kidney cancer	5.24e-05	0.000256	CcSEcCtD
Donepezil—Somnolence—Paclitaxel—kidney cancer	5.23e-05	0.000255	CcSEcCtD
Donepezil—Rash—Dactinomycin—kidney cancer	5.22e-05	0.000255	CcSEcCtD
Donepezil—Nausea—Sunitinib—kidney cancer	5.2e-05	0.000254	CcSEcCtD
Donepezil—Loss of consciousness—Capecitabine—kidney cancer	5.19e-05	0.000254	CcSEcCtD
Donepezil—Dyspepsia—Paclitaxel—kidney cancer	5.17e-05	0.000253	CcSEcCtD
Donepezil—Cough—Capecitabine—kidney cancer	5.16e-05	0.000252	CcSEcCtD
Donepezil—Dysuria—Doxorubicin—kidney cancer	5.11e-05	0.00025	CcSEcCtD
Donepezil—Decreased appetite—Paclitaxel—kidney cancer	5.11e-05	0.000249	CcSEcCtD
Donepezil—Hypertension—Capecitabine—kidney cancer	5.1e-05	0.000249	CcSEcCtD
Donepezil—Gastrointestinal disorder—Paclitaxel—kidney cancer	5.07e-05	0.000248	CcSEcCtD
Donepezil—Fatigue—Paclitaxel—kidney cancer	5.07e-05	0.000247	CcSEcCtD
Donepezil—Diarrhoea—Vincristine—kidney cancer	5.06e-05	0.000247	CcSEcCtD
Donepezil—Pollakiuria—Doxorubicin—kidney cancer	5.05e-05	0.000247	CcSEcCtD
Donepezil—Asthenia—Gemcitabine—kidney cancer	5.04e-05	0.000246	CcSEcCtD
Donepezil—Arthralgia—Capecitabine—kidney cancer	5.03e-05	0.000246	CcSEcCtD
Donepezil—Myalgia—Capecitabine—kidney cancer	5.03e-05	0.000246	CcSEcCtD
Donepezil—Chest pain—Capecitabine—kidney cancer	5.03e-05	0.000246	CcSEcCtD
Donepezil—Pain—Paclitaxel—kidney cancer	5.03e-05	0.000245	CcSEcCtD
Donepezil—Constipation—Paclitaxel—kidney cancer	5.03e-05	0.000245	CcSEcCtD
Donepezil—Anxiety—Capecitabine—kidney cancer	5.01e-05	0.000245	CcSEcCtD
Donepezil—Weight increased—Doxorubicin—kidney cancer	4.98e-05	0.000243	CcSEcCtD
Donepezil—Discomfort—Capecitabine—kidney cancer	4.97e-05	0.000243	CcSEcCtD
Donepezil—Pruritus—Gemcitabine—kidney cancer	4.97e-05	0.000242	CcSEcCtD
Donepezil—Weight decreased—Doxorubicin—kidney cancer	4.95e-05	0.000241	CcSEcCtD
Donepezil—Hyperglycaemia—Doxorubicin—kidney cancer	4.93e-05	0.000241	CcSEcCtD
Donepezil—Dry mouth—Capecitabine—kidney cancer	4.92e-05	0.00024	CcSEcCtD
Donepezil—Nausea—Dactinomycin—kidney cancer	4.92e-05	0.00024	CcSEcCtD
Donepezil—Pneumonia—Doxorubicin—kidney cancer	4.9e-05	0.000239	CcSEcCtD
Donepezil—Dizziness—Vincristine—kidney cancer	4.89e-05	0.000239	CcSEcCtD
Donepezil—Infestation NOS—Doxorubicin—kidney cancer	4.87e-05	0.000238	CcSEcCtD
Donepezil—Infestation—Doxorubicin—kidney cancer	4.87e-05	0.000238	CcSEcCtD
Donepezil—Confusional state—Capecitabine—kidney cancer	4.86e-05	0.000237	CcSEcCtD
Donepezil—Feeling abnormal—Paclitaxel—kidney cancer	4.84e-05	0.000236	CcSEcCtD
Donepezil—Oedema—Capecitabine—kidney cancer	4.82e-05	0.000235	CcSEcCtD
Donepezil—Gastrointestinal pain—Paclitaxel—kidney cancer	4.81e-05	0.000235	CcSEcCtD
Donepezil—Diarrhoea—Gemcitabine—kidney cancer	4.8e-05	0.000234	CcSEcCtD
Donepezil—Renal failure—Doxorubicin—kidney cancer	4.79e-05	0.000234	CcSEcCtD
Donepezil—Infection—Capecitabine—kidney cancer	4.79e-05	0.000234	CcSEcCtD
Donepezil—Jaundice—Doxorubicin—kidney cancer	4.75e-05	0.000232	CcSEcCtD
Donepezil—Shock—Capecitabine—kidney cancer	4.75e-05	0.000232	CcSEcCtD
Donepezil—Conjunctivitis—Doxorubicin—kidney cancer	4.74e-05	0.000231	CcSEcCtD
Donepezil—Urinary tract infection—Doxorubicin—kidney cancer	4.74e-05	0.000231	CcSEcCtD
Donepezil—Nervous system disorder—Capecitabine—kidney cancer	4.73e-05	0.000231	CcSEcCtD
Donepezil—Thrombocytopenia—Capecitabine—kidney cancer	4.72e-05	0.000231	CcSEcCtD
Donepezil—Vomiting—Vincristine—kidney cancer	4.7e-05	0.00023	CcSEcCtD
Donepezil—Sweating—Doxorubicin—kidney cancer	4.67e-05	0.000228	CcSEcCtD
Donepezil—Urticaria—Paclitaxel—kidney cancer	4.67e-05	0.000228	CcSEcCtD
Donepezil—Rash—Vincristine—kidney cancer	4.67e-05	0.000228	CcSEcCtD
Donepezil—Hyperhidrosis—Capecitabine—kidney cancer	4.66e-05	0.000228	CcSEcCtD
Donepezil—Dermatitis—Vincristine—kidney cancer	4.66e-05	0.000228	CcSEcCtD
Donepezil—Haematuria—Doxorubicin—kidney cancer	4.65e-05	0.000227	CcSEcCtD
Donepezil—Abdominal pain—Paclitaxel—kidney cancer	4.65e-05	0.000227	CcSEcCtD
Donepezil—Body temperature increased—Paclitaxel—kidney cancer	4.65e-05	0.000227	CcSEcCtD
Donepezil—Headache—Vincristine—kidney cancer	4.64e-05	0.000226	CcSEcCtD
Donepezil—Epistaxis—Doxorubicin—kidney cancer	4.6e-05	0.000224	CcSEcCtD
Donepezil—Anorexia—Capecitabine—kidney cancer	4.6e-05	0.000224	CcSEcCtD
Donepezil—Hypotension—Capecitabine—kidney cancer	4.51e-05	0.00022	CcSEcCtD
Donepezil—Vomiting—Gemcitabine—kidney cancer	4.46e-05	0.000218	CcSEcCtD
Donepezil—Bradycardia—Doxorubicin—kidney cancer	4.46e-05	0.000217	CcSEcCtD
Donepezil—Rash—Gemcitabine—kidney cancer	4.43e-05	0.000216	CcSEcCtD
Donepezil—Dermatitis—Gemcitabine—kidney cancer	4.42e-05	0.000216	CcSEcCtD
Donepezil—Haemoglobin—Doxorubicin—kidney cancer	4.4e-05	0.000215	CcSEcCtD
Donepezil—Headache—Gemcitabine—kidney cancer	4.4e-05	0.000215	CcSEcCtD
Donepezil—Nausea—Vincristine—kidney cancer	4.4e-05	0.000215	CcSEcCtD
Donepezil—Musculoskeletal discomfort—Capecitabine—kidney cancer	4.39e-05	0.000215	CcSEcCtD
Donepezil—Rhinitis—Doxorubicin—kidney cancer	4.39e-05	0.000214	CcSEcCtD
Donepezil—Hepatitis—Doxorubicin—kidney cancer	4.38e-05	0.000214	CcSEcCtD
Donepezil—Haemorrhage—Doxorubicin—kidney cancer	4.38e-05	0.000214	CcSEcCtD
Donepezil—Insomnia—Capecitabine—kidney cancer	4.36e-05	0.000213	CcSEcCtD
Donepezil—Hypoaesthesia—Doxorubicin—kidney cancer	4.35e-05	0.000213	CcSEcCtD
Donepezil—Pharyngitis—Doxorubicin—kidney cancer	4.34e-05	0.000212	CcSEcCtD
Donepezil—Paraesthesia—Capecitabine—kidney cancer	4.33e-05	0.000211	CcSEcCtD
Donepezil—Hypersensitivity—Paclitaxel—kidney cancer	4.33e-05	0.000211	CcSEcCtD
Donepezil—Urinary tract disorder—Doxorubicin—kidney cancer	4.32e-05	0.000211	CcSEcCtD
Donepezil—Oedema peripheral—Doxorubicin—kidney cancer	4.31e-05	0.00021	CcSEcCtD
Donepezil—Dyspnoea—Capecitabine—kidney cancer	4.3e-05	0.00021	CcSEcCtD
Donepezil—Urethral disorder—Doxorubicin—kidney cancer	4.29e-05	0.000209	CcSEcCtD
Donepezil—Dyspepsia—Capecitabine—kidney cancer	4.25e-05	0.000207	CcSEcCtD
Donepezil—Visual impairment—Doxorubicin—kidney cancer	4.22e-05	0.000206	CcSEcCtD
Donepezil—Asthenia—Paclitaxel—kidney cancer	4.22e-05	0.000206	CcSEcCtD
Donepezil—Decreased appetite—Capecitabine—kidney cancer	4.19e-05	0.000205	CcSEcCtD
Donepezil—Nausea—Gemcitabine—kidney cancer	4.17e-05	0.000204	CcSEcCtD
Donepezil—Gastrointestinal disorder—Capecitabine—kidney cancer	4.16e-05	0.000203	CcSEcCtD
Donepezil—Fatigue—Capecitabine—kidney cancer	4.16e-05	0.000203	CcSEcCtD
Donepezil—Pruritus—Paclitaxel—kidney cancer	4.16e-05	0.000203	CcSEcCtD
Donepezil—Pain—Capecitabine—kidney cancer	4.12e-05	0.000201	CcSEcCtD
Donepezil—Constipation—Capecitabine—kidney cancer	4.12e-05	0.000201	CcSEcCtD
Donepezil—Tinnitus—Doxorubicin—kidney cancer	4.08e-05	0.000199	CcSEcCtD
Donepezil—Diarrhoea—Paclitaxel—kidney cancer	4.02e-05	0.000196	CcSEcCtD
Donepezil—Feeling abnormal—Capecitabine—kidney cancer	3.97e-05	0.000194	CcSEcCtD
Donepezil—Gastrointestinal pain—Capecitabine—kidney cancer	3.94e-05	0.000193	CcSEcCtD
Donepezil—Chills—Doxorubicin—kidney cancer	3.93e-05	0.000192	CcSEcCtD
Donepezil—Arrhythmia—Doxorubicin—kidney cancer	3.91e-05	0.000191	CcSEcCtD
Donepezil—Dizziness—Paclitaxel—kidney cancer	3.89e-05	0.00019	CcSEcCtD
Donepezil—Alopecia—Doxorubicin—kidney cancer	3.87e-05	0.000189	CcSEcCtD
Donepezil—Mental disorder—Doxorubicin—kidney cancer	3.83e-05	0.000187	CcSEcCtD
Donepezil—Urticaria—Capecitabine—kidney cancer	3.83e-05	0.000187	CcSEcCtD
Donepezil—Body temperature increased—Capecitabine—kidney cancer	3.81e-05	0.000186	CcSEcCtD
Donepezil—Abdominal pain—Capecitabine—kidney cancer	3.81e-05	0.000186	CcSEcCtD
Donepezil—Erythema—Doxorubicin—kidney cancer	3.81e-05	0.000186	CcSEcCtD
Donepezil—Malnutrition—Doxorubicin—kidney cancer	3.81e-05	0.000186	CcSEcCtD
Donepezil—Flatulence—Doxorubicin—kidney cancer	3.75e-05	0.000183	CcSEcCtD
Donepezil—Tension—Doxorubicin—kidney cancer	3.74e-05	0.000182	CcSEcCtD
Donepezil—Vomiting—Paclitaxel—kidney cancer	3.74e-05	0.000182	CcSEcCtD
Donepezil—Dysgeusia—Doxorubicin—kidney cancer	3.73e-05	0.000182	CcSEcCtD
Donepezil—Rash—Paclitaxel—kidney cancer	3.71e-05	0.000181	CcSEcCtD
Donepezil—Dermatitis—Paclitaxel—kidney cancer	3.7e-05	0.000181	CcSEcCtD
Donepezil—Nervousness—Doxorubicin—kidney cancer	3.7e-05	0.000181	CcSEcCtD
Donepezil—Back pain—Doxorubicin—kidney cancer	3.68e-05	0.00018	CcSEcCtD
Donepezil—Headache—Paclitaxel—kidney cancer	3.68e-05	0.00018	CcSEcCtD
Donepezil—Muscle spasms—Doxorubicin—kidney cancer	3.66e-05	0.000179	CcSEcCtD
Donepezil—Vision blurred—Doxorubicin—kidney cancer	3.59e-05	0.000175	CcSEcCtD
Donepezil—Hypersensitivity—Capecitabine—kidney cancer	3.55e-05	0.000173	CcSEcCtD
Donepezil—Ill-defined disorder—Doxorubicin—kidney cancer	3.53e-05	0.000173	CcSEcCtD
Donepezil—Anaemia—Doxorubicin—kidney cancer	3.52e-05	0.000172	CcSEcCtD
Donepezil—Agitation—Doxorubicin—kidney cancer	3.5e-05	0.000171	CcSEcCtD
Donepezil—Nausea—Paclitaxel—kidney cancer	3.49e-05	0.00017	CcSEcCtD
Donepezil—Asthenia—Capecitabine—kidney cancer	3.46e-05	0.000169	CcSEcCtD
Donepezil—Malaise—Doxorubicin—kidney cancer	3.44e-05	0.000168	CcSEcCtD
Donepezil—Vertigo—Doxorubicin—kidney cancer	3.42e-05	0.000167	CcSEcCtD
Donepezil—Syncope—Doxorubicin—kidney cancer	3.42e-05	0.000167	CcSEcCtD
Donepezil—Pruritus—Capecitabine—kidney cancer	3.41e-05	0.000167	CcSEcCtD
Donepezil—Loss of consciousness—Doxorubicin—kidney cancer	3.35e-05	0.000163	CcSEcCtD
Donepezil—Cough—Doxorubicin—kidney cancer	3.32e-05	0.000162	CcSEcCtD
Donepezil—Convulsion—Doxorubicin—kidney cancer	3.3e-05	0.000161	CcSEcCtD
Donepezil—Diarrhoea—Capecitabine—kidney cancer	3.3e-05	0.000161	CcSEcCtD
Donepezil—Hypertension—Doxorubicin—kidney cancer	3.29e-05	0.000161	CcSEcCtD
Donepezil—Myalgia—Doxorubicin—kidney cancer	3.24e-05	0.000158	CcSEcCtD
Donepezil—Arthralgia—Doxorubicin—kidney cancer	3.24e-05	0.000158	CcSEcCtD
Donepezil—Chest pain—Doxorubicin—kidney cancer	3.24e-05	0.000158	CcSEcCtD
Donepezil—Anxiety—Doxorubicin—kidney cancer	3.23e-05	0.000158	CcSEcCtD
Donepezil—Discomfort—Doxorubicin—kidney cancer	3.2e-05	0.000156	CcSEcCtD
Donepezil—Dizziness—Capecitabine—kidney cancer	3.19e-05	0.000156	CcSEcCtD
Donepezil—Dry mouth—Doxorubicin—kidney cancer	3.17e-05	0.000155	CcSEcCtD
Donepezil—Confusional state—Doxorubicin—kidney cancer	3.13e-05	0.000153	CcSEcCtD
Donepezil—Oedema—Doxorubicin—kidney cancer	3.11e-05	0.000152	CcSEcCtD
Donepezil—Infection—Doxorubicin—kidney cancer	3.09e-05	0.000151	CcSEcCtD
Donepezil—Vomiting—Capecitabine—kidney cancer	3.07e-05	0.00015	CcSEcCtD
Donepezil—Shock—Doxorubicin—kidney cancer	3.06e-05	0.000149	CcSEcCtD
Donepezil—Nervous system disorder—Doxorubicin—kidney cancer	3.05e-05	0.000149	CcSEcCtD
Donepezil—Thrombocytopenia—Doxorubicin—kidney cancer	3.04e-05	0.000149	CcSEcCtD
Donepezil—Rash—Capecitabine—kidney cancer	3.04e-05	0.000148	CcSEcCtD
Donepezil—Dermatitis—Capecitabine—kidney cancer	3.04e-05	0.000148	CcSEcCtD
Donepezil—Headache—Capecitabine—kidney cancer	3.02e-05	0.000147	CcSEcCtD
Donepezil—Hyperhidrosis—Doxorubicin—kidney cancer	3.01e-05	0.000147	CcSEcCtD
Donepezil—Anorexia—Doxorubicin—kidney cancer	2.96e-05	0.000145	CcSEcCtD
Donepezil—Hypotension—Doxorubicin—kidney cancer	2.91e-05	0.000142	CcSEcCtD
Donepezil—Nausea—Capecitabine—kidney cancer	2.86e-05	0.00014	CcSEcCtD
Donepezil—Musculoskeletal discomfort—Doxorubicin—kidney cancer	2.83e-05	0.000138	CcSEcCtD
Donepezil—Insomnia—Doxorubicin—kidney cancer	2.81e-05	0.000137	CcSEcCtD
Donepezil—Paraesthesia—Doxorubicin—kidney cancer	2.79e-05	0.000136	CcSEcCtD
Donepezil—Dyspnoea—Doxorubicin—kidney cancer	2.77e-05	0.000135	CcSEcCtD
Donepezil—Somnolence—Doxorubicin—kidney cancer	2.76e-05	0.000135	CcSEcCtD
Donepezil—Dyspepsia—Doxorubicin—kidney cancer	2.74e-05	0.000134	CcSEcCtD
Donepezil—Decreased appetite—Doxorubicin—kidney cancer	2.7e-05	0.000132	CcSEcCtD
Donepezil—Gastrointestinal disorder—Doxorubicin—kidney cancer	2.68e-05	0.000131	CcSEcCtD
Donepezil—Fatigue—Doxorubicin—kidney cancer	2.68e-05	0.000131	CcSEcCtD
Donepezil—Pain—Doxorubicin—kidney cancer	2.66e-05	0.00013	CcSEcCtD
Donepezil—Constipation—Doxorubicin—kidney cancer	2.66e-05	0.00013	CcSEcCtD
Donepezil—Feeling abnormal—Doxorubicin—kidney cancer	2.56e-05	0.000125	CcSEcCtD
Donepezil—Gastrointestinal pain—Doxorubicin—kidney cancer	2.54e-05	0.000124	CcSEcCtD
Donepezil—Urticaria—Doxorubicin—kidney cancer	2.47e-05	0.000121	CcSEcCtD
Donepezil—Body temperature increased—Doxorubicin—kidney cancer	2.46e-05	0.00012	CcSEcCtD
Donepezil—Abdominal pain—Doxorubicin—kidney cancer	2.46e-05	0.00012	CcSEcCtD
Donepezil—Hypersensitivity—Doxorubicin—kidney cancer	2.29e-05	0.000112	CcSEcCtD
Donepezil—Asthenia—Doxorubicin—kidney cancer	2.23e-05	0.000109	CcSEcCtD
Donepezil—Pruritus—Doxorubicin—kidney cancer	2.2e-05	0.000107	CcSEcCtD
Donepezil—Diarrhoea—Doxorubicin—kidney cancer	2.13e-05	0.000104	CcSEcCtD
Donepezil—Dizziness—Doxorubicin—kidney cancer	2.06e-05	0.0001	CcSEcCtD
Donepezil—Vomiting—Doxorubicin—kidney cancer	1.98e-05	9.65e-05	CcSEcCtD
Donepezil—Rash—Doxorubicin—kidney cancer	1.96e-05	9.57e-05	CcSEcCtD
Donepezil—Dermatitis—Doxorubicin—kidney cancer	1.96e-05	9.56e-05	CcSEcCtD
Donepezil—Headache—Doxorubicin—kidney cancer	1.95e-05	9.51e-05	CcSEcCtD
Donepezil—Nausea—Doxorubicin—kidney cancer	1.85e-05	9.01e-05	CcSEcCtD
Donepezil—ACHE—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	1.47e-05	0.000984	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—ACY1—kidney cancer	1.45e-05	0.000969	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—AKAP13—kidney cancer	1.43e-05	0.000961	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—ACY1—kidney cancer	1.43e-05	0.000961	CbGpPWpGaD
Donepezil—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—kidney cancer	1.43e-05	0.000956	CbGpPWpGaD
Donepezil—HTR2A—SIDS Susceptibility Pathways—VEGFA—kidney cancer	1.4e-05	0.000941	CbGpPWpGaD
Donepezil—ACHE—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	1.35e-05	0.000904	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—ITPR2—kidney cancer	1.34e-05	0.0009	CbGpPWpGaD
Donepezil—ACHE—Metabolism—CRABP1—kidney cancer	1.34e-05	0.000897	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—IGF2—kidney cancer	1.34e-05	0.000897	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—CDKN2B—kidney cancer	1.33e-05	0.000893	CbGpPWpGaD
Donepezil—ACHE—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	1.3e-05	0.000874	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—IGF1R—kidney cancer	1.29e-05	0.000867	CbGpPWpGaD
Donepezil—HTR2A—Class A/1 (Rhodopsin-like receptors)—POMC—kidney cancer	1.28e-05	0.000858	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—RAF1—kidney cancer	1.25e-05	0.000835	CbGpPWpGaD
Donepezil—ACHE—Metabolism—ITPR2—kidney cancer	1.24e-05	0.000834	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CER1—kidney cancer	1.24e-05	0.000828	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—GPC3—kidney cancer	1.24e-05	0.000828	CbGpPWpGaD
Donepezil—CYP3A4—Biological oxidations—GSTP1—kidney cancer	1.23e-05	0.000827	CbGpPWpGaD
Donepezil—HRH3—GPCR downstream signaling—IL2—kidney cancer	1.23e-05	0.000825	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—PDHB—kidney cancer	1.23e-05	0.000824	CbGpPWpGaD
Donepezil—CYP2D6—Biological oxidations—POMC—kidney cancer	1.23e-05	0.000821	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	1.22e-05	0.000819	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—ITPR2—kidney cancer	1.22e-05	0.000817	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—PDHB—kidney cancer	1.22e-05	0.000817	CbGpPWpGaD
Donepezil—CYP3A4—Metapathway biotransformation—GSTP1—kidney cancer	1.22e-05	0.000815	CbGpPWpGaD
Donepezil—CYP2C9—Biological oxidations—POMC—kidney cancer	1.21e-05	0.000814	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—CCBL1—kidney cancer	1.16e-05	0.000775	CbGpPWpGaD
Donepezil—ACHE—Neuronal System—MAPK1—kidney cancer	1.15e-05	0.000769	CbGpPWpGaD
Donepezil—ACHE—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.15e-05	0.000769	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—CCBL1—kidney cancer	1.15e-05	0.000768	CbGpPWpGaD
Donepezil—ACHE—Metabolism—GSTT1—kidney cancer	1.13e-05	0.000761	CbGpPWpGaD
Donepezil—CYP3A4—Biological oxidations—GSTM1—kidney cancer	1.13e-05	0.00076	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—ANXA1—kidney cancer	1.12e-05	0.000754	CbGpPWpGaD
Donepezil—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	1.12e-05	0.000749	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—IL2—kidney cancer	1.12e-05	0.000749	CbGpPWpGaD
Donepezil—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	1.07e-05	0.00072	CbGpPWpGaD
Donepezil—ACHE—Metabolism—SCARB1—kidney cancer	1.07e-05	0.00072	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—HIF1A—kidney cancer	1.06e-05	0.000714	CbGpPWpGaD
Donepezil—ACHE—Metabolism—PTGS1—kidney cancer	1.06e-05	0.000713	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—TSC2—kidney cancer	1.06e-05	0.000712	CbGpPWpGaD
Donepezil—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	1.06e-05	0.00071	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—SFRP2—kidney cancer	1.05e-05	0.000704	CbGpPWpGaD
Donepezil—ACHE—Metabolism—PSMD7—kidney cancer	1.04e-05	0.000699	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	1.04e-05	0.000695	CbGpPWpGaD
Donepezil—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—kidney cancer	1.03e-05	0.000689	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—ANXA1—kidney cancer	1.02e-05	0.000685	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—KDR—kidney cancer	1.02e-05	0.000683	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—PPAT—kidney cancer	1e-05	0.000672	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—GLIPR1—kidney cancer	1e-05	0.000672	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—GLIPR1—kidney cancer	9.93e-06	0.000666	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—PPAT—kidney cancer	9.93e-06	0.000666	CbGpPWpGaD
Donepezil—ACHE—Metabolism of proteins—POMC—kidney cancer	9.91e-06	0.000664	CbGpPWpGaD
Donepezil—ACHE—Metabolism—BCHE—kidney cancer	9.88e-06	0.000663	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	9.81e-06	0.000657	CbGpPWpGaD
Donepezil—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—kidney cancer	9.78e-06	0.000655	CbGpPWpGaD
Donepezil—ACHE—Metabolism—SLC5A5—kidney cancer	9.76e-06	0.000655	CbGpPWpGaD
Donepezil—HTR2A—GPCR ligand binding—POMC—kidney cancer	9.75e-06	0.000654	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	9.71e-06	0.000651	CbGpPWpGaD
Donepezil—HTR2A—G alpha (q) signalling events—PIK3CA—kidney cancer	9.49e-06	0.000636	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—ACY1—kidney cancer	9.45e-06	0.000634	CbGpPWpGaD
Donepezil—ACHE—Metabolism—SLC2A1—kidney cancer	9.43e-06	0.000632	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—KIT—kidney cancer	9.38e-06	0.000629	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—APC—kidney cancer	9.38e-06	0.000629	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—APRT—kidney cancer	9.31e-06	0.000624	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—FH—kidney cancer	9.31e-06	0.000624	CbGpPWpGaD
Donepezil—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—kidney cancer	9.23e-06	0.000619	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—APRT—kidney cancer	9.23e-06	0.000619	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—FH—kidney cancer	9.23e-06	0.000619	CbGpPWpGaD
Donepezil—ACHE—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	9.15e-06	0.000613	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	9.03e-06	0.000605	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—MAPK3—kidney cancer	8.98e-06	0.000602	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—POMC—kidney cancer	8.93e-06	0.000598	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—BRAF—kidney cancer	8.82e-06	0.000591	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—GPC3—kidney cancer	8.76e-06	0.000587	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—GPC3—kidney cancer	8.68e-06	0.000582	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—MAPK1—kidney cancer	8.55e-06	0.000573	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—CA2—kidney cancer	8.52e-06	0.000571	CbGpPWpGaD
Donepezil—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—kidney cancer	8.48e-06	0.000569	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CASP2—kidney cancer	8.47e-06	0.000568	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—AKAP13—kidney cancer	8.47e-06	0.000568	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—CA2—kidney cancer	8.45e-06	0.000566	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—ALAD—kidney cancer	8.3e-06	0.000557	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—ALAD—kidney cancer	8.23e-06	0.000552	CbGpPWpGaD
Donepezil—HRH3—GPCR downstream signaling—PIK3CA—kidney cancer	8.17e-06	0.000547	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—ST3GAL2—kidney cancer	8.1e-06	0.000543	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—KRAS—kidney cancer	8.07e-06	0.000541	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—PDHB—kidney cancer	8.04e-06	0.000539	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—ST3GAL2—kidney cancer	8.03e-06	0.000539	CbGpPWpGaD
Donepezil—CYP3A4—Biological oxidations—POMC—kidney cancer	8.01e-06	0.000537	CbGpPWpGaD
Donepezil—ACHE—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	7.98e-06	0.000535	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—ALDH1A1—kidney cancer	7.92e-06	0.000531	CbGpPWpGaD
Donepezil—ACHE—Metabolism—GSTP1—kidney cancer	7.87e-06	0.000527	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—ALDH1A1—kidney cancer	7.85e-06	0.000526	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—GRB7—kidney cancer	7.74e-06	0.000519	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—PGK1—kidney cancer	7.59e-06	0.000509	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—SLC5A3—kidney cancer	7.59e-06	0.000509	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—CCBL1—kidney cancer	7.56e-06	0.000507	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—SLC5A3—kidney cancer	7.53e-06	0.000505	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—PGK1—kidney cancer	7.53e-06	0.000505	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—LDHB—kidney cancer	7.45e-06	0.000499	CbGpPWpGaD
Donepezil—ACHE—Metabolism—ABCB1—kidney cancer	7.45e-06	0.000499	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—PIK3CA—kidney cancer	7.42e-06	0.000497	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—LDHB—kidney cancer	7.38e-06	0.000495	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—RAF1—kidney cancer	7.36e-06	0.000493	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—RELA—kidney cancer	7.33e-06	0.000491	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—ERBB2—kidney cancer	7.28e-06	0.000488	CbGpPWpGaD
Donepezil—ACHE—Metabolism—GSTM1—kidney cancer	7.23e-06	0.000485	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—ITPR2—kidney cancer	7.2e-06	0.000483	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—MTOR—kidney cancer	7.19e-06	0.000482	CbGpPWpGaD
Donepezil—ACHE—Metabolism of proteins—CTNNB1—kidney cancer	7.07e-06	0.000474	CbGpPWpGaD
Donepezil—ACHE—Metabolism—CYP1A1—kidney cancer	6.85e-06	0.000459	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—CDKN1B—kidney cancer	6.74e-06	0.000452	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—IL2—kidney cancer	6.6e-06	0.000442	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—PPAT—kidney cancer	6.55e-06	0.000439	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—GLIPR1—kidney cancer	6.55e-06	0.000439	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CTNNA1—kidney cancer	6.53e-06	0.000438	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—EIF4EBP1—kidney cancer	6.49e-06	0.000435	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—HSPB1—kidney cancer	6.49e-06	0.000435	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—CA9—kidney cancer	6.46e-06	0.000433	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—CCND1—kidney cancer	6.43e-06	0.000431	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—JUN—kidney cancer	6.42e-06	0.00043	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—CA9—kidney cancer	6.4e-06	0.000429	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—CTNNB1—kidney cancer	6.37e-06	0.000427	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	6.26e-06	0.000419	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—PTEN—kidney cancer	6.21e-06	0.000416	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—APRT—kidney cancer	6.09e-06	0.000408	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—FH—kidney cancer	6.09e-06	0.000408	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—PSMD7—kidney cancer	6.03e-06	0.000404	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—ANXA1—kidney cancer	6.03e-06	0.000404	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—TSC1—kidney cancer	6.03e-06	0.000404	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—FLT1—kidney cancer	5.84e-06	0.000392	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—GPC3—kidney cancer	5.73e-06	0.000384	CbGpPWpGaD
Donepezil—ACHE—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	5.63e-06	0.000377	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—VEGFA—kidney cancer	5.61e-06	0.000376	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—CA2—kidney cancer	5.57e-06	0.000373	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—POMC—kidney cancer	5.51e-06	0.000369	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—CRABP1—kidney cancer	5.49e-06	0.000368	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—CRABP1—kidney cancer	5.44e-06	0.000365	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—ALAD—kidney cancer	5.43e-06	0.000364	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—PAK1—kidney cancer	5.42e-06	0.000363	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—JUNB—kidney cancer	5.42e-06	0.000363	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—MAPK3—kidney cancer	5.31e-06	0.000356	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—ST3GAL2—kidney cancer	5.3e-06	0.000355	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—ALDH1A1—kidney cancer	5.18e-06	0.000347	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—MYC—kidney cancer	5.16e-06	0.000346	CbGpPWpGaD
Donepezil—ACHE—Metabolism—POMC—kidney cancer	5.11e-06	0.000342	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—ITPR2—kidney cancer	5.1e-06	0.000342	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—ITPR2—kidney cancer	5.06e-06	0.000339	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—MAPK1—kidney cancer	5.05e-06	0.000338	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—POMC—kidney cancer	5e-06	0.000335	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—PGK1—kidney cancer	4.96e-06	0.000333	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—SLC5A3—kidney cancer	4.96e-06	0.000333	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—LDHB—kidney cancer	4.87e-06	0.000326	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—KRAS—kidney cancer	4.77e-06	0.00032	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	4.66e-06	0.000313	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—GSTT1—kidney cancer	4.65e-06	0.000312	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—ACHE—kidney cancer	4.65e-06	0.000312	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—ACHE—kidney cancer	4.61e-06	0.000309	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—GSTT1—kidney cancer	4.61e-06	0.000309	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—IGF2—kidney cancer	4.43e-06	0.000297	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CDKN2B—kidney cancer	4.41e-06	0.000296	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—SCARB1—kidney cancer	4.41e-06	0.000295	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—PIK3CA—kidney cancer	4.38e-06	0.000294	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—SCARB1—kidney cancer	4.37e-06	0.000293	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—PTGS1—kidney cancer	4.36e-06	0.000292	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—PTGS1—kidney cancer	4.32e-06	0.00029	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—IGF1R—kidney cancer	4.28e-06	0.000287	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—PSMD7—kidney cancer	4.28e-06	0.000287	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—PSMD7—kidney cancer	4.24e-06	0.000284	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—TP53—kidney cancer	4.24e-06	0.000284	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—CA9—kidney cancer	4.22e-06	0.000283	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—RAF1—kidney cancer	4.13e-06	0.000277	CbGpPWpGaD
Donepezil—ACHE—Metabolism—PTGS2—kidney cancer	4.07e-06	0.000273	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—IL2—kidney cancer	4.07e-06	0.000273	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—BCHE—kidney cancer	4.05e-06	0.000272	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—BCHE—kidney cancer	4.02e-06	0.000269	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—SLC5A5—kidney cancer	4e-06	0.000268	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—SLC5A5—kidney cancer	3.97e-06	0.000266	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—SLC2A1—kidney cancer	3.87e-06	0.000259	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—SLC2A1—kidney cancer	3.83e-06	0.000257	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	3.72e-06	0.000249	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—IL2—kidney cancer	3.7e-06	0.000248	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—CRABP1—kidney cancer	3.59e-06	0.000241	CbGpPWpGaD
Donepezil—ACHE—Metabolism—PTEN—kidney cancer	3.55e-06	0.000238	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—HIF1A—kidney cancer	3.52e-06	0.000236	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—TSC2—kidney cancer	3.52e-06	0.000236	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—KDR—kidney cancer	3.37e-06	0.000226	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—ITPR2—kidney cancer	3.34e-06	0.000224	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	3.24e-06	0.000218	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—GSTP1—kidney cancer	3.23e-06	0.000216	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—GSTP1—kidney cancer	3.2e-06	0.000214	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—APC—kidney cancer	3.1e-06	0.000208	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—KIT—kidney cancer	3.1e-06	0.000208	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—ABCB1—kidney cancer	3.05e-06	0.000205	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—ACHE—kidney cancer	3.04e-06	0.000204	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—GSTT1—kidney cancer	3.04e-06	0.000204	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—ABCB1—kidney cancer	3.03e-06	0.000203	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—MAPK3—kidney cancer	2.97e-06	0.000199	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—GSTM1—kidney cancer	2.96e-06	0.000199	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—POMC—kidney cancer	2.96e-06	0.000198	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—GSTM1—kidney cancer	2.94e-06	0.000197	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—BRAF—kidney cancer	2.92e-06	0.000196	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—SCARB1—kidney cancer	2.88e-06	0.000193	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—PTGS1—kidney cancer	2.85e-06	0.000191	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—MAPK1—kidney cancer	2.83e-06	0.00019	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—CYP1A1—kidney cancer	2.81e-06	0.000188	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—PSMD7—kidney cancer	2.8e-06	0.000187	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—CYP1A1—kidney cancer	2.79e-06	0.000187	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—PIK3CA—kidney cancer	2.7e-06	0.000181	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—KRAS—kidney cancer	2.67e-06	0.000179	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—BCHE—kidney cancer	2.65e-06	0.000178	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—SLC5A5—kidney cancer	2.62e-06	0.000176	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—SLC2A1—kidney cancer	2.53e-06	0.00017	CbGpPWpGaD
Donepezil—ACHE—Metabolism—PIK3CA—kidney cancer	2.51e-06	0.000168	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—PIK3CA—kidney cancer	2.46e-06	0.000165	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—RAF1—kidney cancer	2.44e-06	0.000163	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—RELA—kidney cancer	2.43e-06	0.000163	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—ERBB2—kidney cancer	2.41e-06	0.000162	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—MTOR—kidney cancer	2.38e-06	0.000159	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.29e-06	0.000153	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CDKN1B—kidney cancer	2.23e-06	0.00015	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—IL2—kidney cancer	2.18e-06	0.000146	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CCND1—kidney cancer	2.13e-06	0.000143	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—JUN—kidney cancer	2.13e-06	0.000142	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CTNNB1—kidney cancer	2.11e-06	0.000141	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—GSTP1—kidney cancer	2.11e-06	0.000141	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—POMC—kidney cancer	2.1e-06	0.00014	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—POMC—kidney cancer	2.08e-06	0.000139	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—PTEN—kidney cancer	2.06e-06	0.000138	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—ABCB1—kidney cancer	2e-06	0.000134	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—GSTM1—kidney cancer	1.94e-06	0.00013	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—VEGFA—kidney cancer	1.86e-06	0.000124	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—CYP1A1—kidney cancer	1.84e-06	0.000123	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—MAPK3—kidney cancer	1.76e-06	0.000118	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—MYC—kidney cancer	1.71e-06	0.000115	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—MAPK1—kidney cancer	1.67e-06	0.000112	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—PTGS2—kidney cancer	1.67e-06	0.000112	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—PTGS2—kidney cancer	1.66e-06	0.000111	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—KRAS—kidney cancer	1.58e-06	0.000106	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—PTEN—kidney cancer	1.46e-06	9.77e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—PIK3CA—kidney cancer	1.45e-06	9.72e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—PTEN—kidney cancer	1.44e-06	9.69e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—TP53—kidney cancer	1.4e-06	9.41e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—POMC—kidney cancer	1.37e-06	9.18e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—PTGS2—kidney cancer	1.09e-06	7.33e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—PIK3CA—kidney cancer	1.03e-06	6.89e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—PIK3CA—kidney cancer	1.02e-06	6.83e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—PTEN—kidney cancer	9.53e-07	6.39e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—PIK3CA—kidney cancer	6.72e-07	4.51e-05	CbGpPWpGaD
